These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38819619)

  • 1. Cardiovascular risk in patients with acromegaly vs. non-functioning pituitary adenoma following pituitary surgery: an active-comparator cohort study.
    Stocker M; Zimmermann SE; Laager R; Gregoriano C; Mueller B; Schuetz P; Kutz A
    Pituitary; 2024 May; ():. PubMed ID: 38819619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes in patients with Cushing's disease vs nonfunctioning pituitary adenoma after pituitary surgery: an active-comparator cohort study.
    Germann S; Wimmer R; Laager R; Mueller B; Schuetz P; Kaegi-Braun N; Kutz A
    Eur J Endocrinol; 2024 Jul; 191(1):97-105. PubMed ID: 38946089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
    Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
    Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the effects of somatostatin analogue therapy in non-functioning pituitary adenomas in comparison to acromegaly.
    Zawada NB; Kunert-Radek J; Pawlikowski M; Pisarek H; Radek M
    Endokrynol Pol; 2016; 67(3):292-8. PubMed ID: 27345147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term GH replacement therapy on cardiovascular outcomes in GH-deficient patients previously treated for acromegaly: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Bunderen CC; van Varsseveld NC; Heymans MW; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Eur J Endocrinol; 2014 Dec; 171(6):717-26. PubMed ID: 25227133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.
    Tritos NA; Johannsson G; Korbonits M; Miller KK; Feldt-Rasmussen U; Yuen KC; King D; Mattsson AF; Jonsson PJ; Koltowska-Haggstrom M; Klibanski A; Biller BM
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2018-29. PubMed ID: 24694339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotrophin and free alpha-subunit secretion in patients with acromegaly and clinically non-functioning pituitary tumors: anterior pituitary function and the effect of thyrotrophin-releasing hormone.
    Damjanović SS; Popović VP; Petakov MS; Nikolic-Durović MM; Doknić MZ; Gligorović MS
    J Endocrinol Invest; 1996 Nov; 19(10):663-9. PubMed ID: 9007697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, mortality, and cardiovascular diseases in pituitary adenoma in Korea: a nationwide population-based study.
    Oh JS; Kim HJ; Hann HJ; Kang TU; Kim DS; Kang MJ; Lee JY; Shim JJ; Lee MR; Ahn HS
    Pituitary; 2021 Feb; 24(1):38-47. PubMed ID: 32949324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acromegaly and cardiovascular outcomes: a cohort study.
    Hong S; Kim KS; Han K; Park CY
    Eur Heart J; 2022 Apr; 43(15):1491-1499. PubMed ID: 34864952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery.
    Yao X; Gersh BJ; Holmes DR; Melduni RM; Johnsrud DO; Sangaralingham LR; Shah ND; Noseworthy PA
    JAMA; 2018 May; 319(20):2116-2126. PubMed ID: 29800182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma.
    Webb SM; Mo D; Lamberts SW; Melmed S; Cavagnini F; Pecori Giraldi F; Strasburger CJ; Zimmermann AG; Woodmansee WW;
    J Clin Endocrinol Metab; 2010 Feb; 95(2):630-8. PubMed ID: 20022992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Life Changes Before and After Transsphenoidal Surgery for Sellar and Parasellar Lesions.
    Ishikawa T; Takeuchi K; Nagatani T; Aimi Y; Tanemura E; Tambara M; Nagata Y; Choo J; Wakabayashi T
    World Neurosurg; 2019 Feb; 122():e1202-e1210. PubMed ID: 30447458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sevoflurane anesthesia rather than propofol anesthesia is associated with 3-month postoperative hypocortisolism in patients undergoing endoscopic transsphenoidal surgery for non-functional pituitary adenoma with preoperative normal hypothalamic-pituitary-adrenal axis.
    Choi S; Kim YJ; Oh H; Kim N; Kim YH; Park HP
    Acta Neurochir (Wien); 2022 Aug; 164(8):2083-2094. PubMed ID: 35641648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life is significantly impaired in both secretory and non-functioning pituitary adenomas.
    Vega-Beyhart A; Enriquez-Estrada VM; Bello-Chavolla OY; Torres-Victoria TR; Martínez-Sánchez FD; López-Navarro JM; Pérez-Guzmán MC; Hinojosa-Amaya JM; León-Suárez A; Espinoza-Salazar HD; Roldán-Sarmiento P; Gómez-Sámano MA; Gómez-Pérez FJ; Cuevas-Ramos D
    Clin Endocrinol (Oxf); 2019 Mar; 90(3):457-467. PubMed ID: 30548674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.
    Ragnarsson O; Höybye C; Jönsson PJ; Feldt-Rasmussen U; Johannsson G; Biller BM; Koltowska-Häggström M
    Eur J Endocrinol; 2012 Apr; 166(4):593-600. PubMed ID: 22258111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antipituitary antibodies in acromegaly.
    Guaraldi F; Caturegli P; Salvatori R
    Pituitary; 2012 Dec; 15(4):490-4. PubMed ID: 22002711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk profile in growth hormone-treated adults with craniopharyngioma compared to non-functioning pituitary adenoma: a national cohort study.
    Verweij T; Slagboom TNA; van Varsseveld NC; van der Lely AJ; Drent ML; van Bunderen CC
    Eur J Endocrinol; 2021 Oct; 185(6):793-801. PubMed ID: 34605771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
    Verhelst J; Kendall-Taylor P; Erfurth EM; Price DA; Geffner M; Koltowska-Häggström M; Jönsson PJ; Wilton P; Abs R
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study.
    Zhang M; Solomon DH; Desai RJ; Kang EH; Liu J; Neogi T; Kim SC
    Circulation; 2018 Sep; 138(11):1116-1126. PubMed ID: 29899013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.